Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
RPHM

RPHM - Reneo Pharmaceuticals, Inc. Stock Price, Fair Value and News

$14.16-0.04 (-0.28%)
Market Closed

Price Targets

RPHM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RPHM Price Action

RPHM RSI Chart

RPHM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RPHM Valuation

Market Cap

208.6M

Price/Earnings (Trailing)

-3.29

Price/Sales (Trailing)

50.56

Price/Free Cashflow

-3.4

RPHM Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

RPHM Fundamentals

RPHM Revenue

Revenue (TTM)

4.1M

Rev. Growth (Yr)

362.07%

Rev. Growth (Qtr)

-13.92%

RPHM Earnings

Earnings (TTM)

-63.5M

Earnings Growth (Yr)

-27.2%

Earnings Growth (Qtr)

4.49%

RPHM Profitability

Return on Equity

-95.53%

Return on Assets

-87.12%

Free Cashflow Yield

-29.44%

RPHM Investor Care

Shares Dilution (1Y)

4178.66%

Diluted EPS (TTM)

93.06

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.8M3.5M4.1M0
20241.7M1.8M1.9M2.0M
20230001.6M
Get all data in R, Python etc through our Historical Stock Data APIs

About Reneo Pharmaceuticals, Inc.

RPHM
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.
 CEO
 WEBSITEhttps://reneopharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES51

Reneo Pharmaceuticals, Inc. Frequently Asked Questions

RPHM is the stock ticker symbol of Reneo Pharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Sep 30 2025, market cap of Reneo Pharmaceuticals, Inc. is 208.65 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check RPHM's fair value in chart for subscribers.

The fair value guage provides a quick view whether RPHM is over valued or under valued. Whether Reneo Pharmaceuticals, Inc. is cheap or expensive depends on the assumptions which impact Reneo Pharmaceuticals, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RPHM.

As of Tue Sep 30 2025, RPHM's PE ratio (Price to Earnings) is -3.29 and Price to Sales (PS) ratio is 50.56. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RPHM PE ratio will change depending on the future growth rate expectations of investors.